|
2J62
Structure of a bacterial O-glcnacase in complex with glcnacstatin
Deposited 2006-09-22
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
31–624(594 aa)
Fragment:RESIDUES 31-624
Chain B
31–624(594 aa)
Fragment:RESIDUES 31-624
|
Not recorded
|
CL CHLORIDE ION × 4
GSZ N-[(5R,6R,7R,8S)-6,7-DIHYDROXY-5-(HYDROXYMETHYL)-2-(2-PHENYLETHYL)-1,5,6,7,8,8A-HEXAHYDROIMIDAZO[1,2-A]PYRIDIN-8-YL]-2-METHYLPROPANAMIDE × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.26 Å
R-free 0.219
|
|
2JH2
X-ray crystal structure of a cohesin-like module from Clostridium perfringens
Deposited 2007-02-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
768–909(142 aa)
Fragment:RESIDUES 768-909
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.50 Å
R-free 0.295
|
|
2JH2
X-ray crystal structure of a cohesin-like module from Clostridium perfringens
Deposited 2007-02-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
768–909(142 aa)
Fragment:RESIDUES 768-909
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.50 Å
R-free 0.295
|
|
2JH2
X-ray crystal structure of a cohesin-like module from Clostridium perfringens
Deposited 2007-02-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
768–909(142 aa)
Fragment:RESIDUES 768-909
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.50 Å
R-free 0.295
|
|
2O4E
The solution structure of a protein-protein interaction module from a family 84 glycoside hydrolase of Clostridium perfringens
Deposited 2006-12-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
768–909(142 aa)
Fragment:Putative protein-protein interaction module
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Pressure 1
NMR sample composition
1mM U-15N,13C x82, 25mM hepes, 50mM nacl, 5mM cacl2, pH 7.0
|
Resolution not provided
|
|
2OZN
The Cohesin-Dockerin Complex of NagJ and NagH from Clostridium perfringens
Deposited 2007-02-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
768–909(142 aa)
Fragment:Cohesin module (residues 768-909)
|
Not recorded
|
CL CHLORIDE ION × 1
CA CALCIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.5;21% (w/v) polyethylene glycol 2000, 0.2M ammonium sulfate, 100mM sodium acetate, pH 4.5
|
Resolution 1.60 Å
R-free 0.246
|
|
2V5C
Family 84 glycoside hydrolase from Clostridium perfringens, 2.1 Angstrom structure
Deposited 2008-10-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
31–624(594 aa)
Fragment:CATALYTIC MODULE, RESIDUES 31-624
|
Not recorded
|
CA CALCIUM ION × 2
CAC CACODYLATE ION × 3
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.10 Å
R-free 0.255
|
|
2V5C
Family 84 glycoside hydrolase from Clostridium perfringens, 2.1 Angstrom structure
Deposited 2008-10-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
31–624(594 aa)
Fragment:CATALYTIC MODULE, RESIDUES 31-624
|
Not recorded
|
CA CALCIUM ION × 2
CAC CACODYLATE ION × 2
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.10 Å
R-free 0.255
|
|
2V5D
Structure of a Family 84 Glycoside Hydrolase and a Family 32 Carbohydrate-Binding Module in Tandem from Clostridium perfringens.
Deposited 2008-10-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
31–767(737 aa)
Fragment:RESIDUES 31-767
|
Not recorded
|
CA CALCIUM ION × 3
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 3.30 Å
R-free 0.370
|
|
2VUR
Chemical dissection of the link between Streptozotocin, O-GlcNAc and pancreatic cell death
Deposited 2008-05-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
31–624(594 aa)
Fragment:O-GLCNACASE DOMAIN, RESIDUES 31-624
|
Not recorded
|
YX1 2-deoxy-2-{[(2-hydroxy-1-methylhydrazino)carbonyl]amino}-beta-D-glucopyranose × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.20 Å
R-free 0.241
|
|
2VUR
Chemical dissection of the link between Streptozotocin, O-GlcNAc and pancreatic cell death
Deposited 2008-05-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
31–624(594 aa)
Fragment:O-GLCNACASE DOMAIN, RESIDUES 31-624
|
Not recorded
|
YX1 2-deoxy-2-{[(2-hydroxy-1-methylhydrazino)carbonyl]amino}-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.20 Å
R-free 0.241
|
|
2WB5
GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation
Deposited 2009-02-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
31–624(594 aa)
Fragment:O-GLCNACASE DOMAIN, RESIDUES 31-624
|
Not recorded
|
CL CHLORIDE ION × 2
NA SODIUM ION × 1
VGB (5R,6R,7R,8S)-6,7-dihydroxy-5-(hydroxymethyl)-2-(2-phenylethyl)-8-(propanoylamino)-5,6,7,8-tetrahydro-1H-imidazo[1,2-a]pyridin-4-ium × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;30% PEG 8000, 0.2 M AMMONIUM SULFATE, 0.1 M SODIUM COCADYLATE, pH 6.5
|
Resolution 2.31 Å
R-free 0.237
|
|
2WB5
GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation
Deposited 2009-02-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
31–624(594 aa)
Fragment:O-GLCNACASE DOMAIN, RESIDUES 31-624
|
Not recorded
|
CL CHLORIDE ION × 3
VGB (5R,6R,7R,8S)-6,7-dihydroxy-5-(hydroxymethyl)-2-(2-phenylethyl)-8-(propanoylamino)-5,6,7,8-tetrahydro-1H-imidazo[1,2-a]pyridin-4-ium × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;30% PEG 8000, 0.2 M AMMONIUM SULFATE, 0.1 M SODIUM COCADYLATE, pH 6.5
|
Resolution 2.31 Å
R-free 0.237
|
|
2X0Y
Screening-based discovery of drug-like O-GlcNAcase inhibitor scaffolds
Deposited 2009-12-18
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
31–624(594 aa)
Fragment:RESIDUES 31-624
Chain B
31–624(594 aa)
Fragment:RESIDUES 31-624
|
Not recorded
|
X0T 7-[(2S)-2,3-DIHYDROXYPROPYL]-1,3-DIMETHYL-3,7-DIHYDRO-1H-PURINE-2,6-DIONE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
0.2 M AMMONIUM SULFATE, 0.1 M SODIUM CACODYLATE PH 6.5 AND 30 % PEG 8000 AND GAMMA-BUTYROLACTONE
|
Resolution 2.25 Å
R-free 0.246
|
|
2XPK
Cell-penetrant, nanomolar O-GlcNAcase inhibitors selective against lysosomal hexosaminidases
Deposited 2010-08-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
31–624(594 aa)
Fragment:RESIDUES 31-624
Chain B
31–624(594 aa)
Fragment:RESIDUES 31-624
|
Mutation:YES
Mutation:YES
|
Z0M N-[(5R,6R,7R,8S)-6,7-DIHYDROXY-5-(HYDROXYMETHYL)-2-(2-PHENYLETHYL)-5,6,7,8-TETRAHYDROIMIDAZO[1,2-A]PYRIDIN-8-YL]-3-SULFANYLPROPANAMIDE × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.40 Å
R-free 0.242
|
|
2YDQ
CpOGA D298N in complex with hOGA-derived O-GlcNAc peptide
Deposited 2011-03-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
31–618(588 aa)
Fragment:RESIDUES 31-618
|
Mutation:YES
|
CD CADMIUM ION × 19
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;0.6M NAAC, 0.175M CDSO4, 0.1M HEPES PH 7.5
|
Resolution 2.60 Å
R-free 0.231
|
|
2YDR
CpOGA D298N in complex with p53-derived O-GlcNAc peptide
Deposited 2011-03-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
31–618(588 aa)
Fragment:RESIDUES 31-618
|
Mutation:YES
|
CD CADMIUM ION × 18
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;0.6 M NAAC, 0.175 M CDSO4, 0.1 M HEPES PH 7.5
|
Resolution 2.75 Å
R-free 0.219
|
|
2YDS
CpOGA D298N in complex with TAB1-derived O-GlcNAc peptide
Deposited 2011-03-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
31–618(588 aa)
Fragment:RESIDUES 31-618
|
Mutation:YES
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
CD CADMIUM ION × 19
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;pH 8.5
|
Resolution 2.55 Å
R-free 0.238
|
|
4ZXL
CpOGA D298N in complex with Drosophila HCF -derived Thr-O-GlcNAc peptide
Deposited 2015-05-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
39–617(579 aa)
Fragment:UNP residues 39-617
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
CD CADMIUM ION × 15
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295.15 K;CpOGA D298N was concentrated to 35 mg/ml in 25 mM Tris/HCl (pH 8.0) and crystallized from 0.175 M CdSO4 and 0.6 M sodium acetate pH 7.5
|
Resolution 2.60 Å
R-free 0.220
|
|
5OXD
Complex of a C. perfringens O-GlcNAcase with a fragment hit
Deposited 2017-09-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
31–618(588 aa)
|
Not recorded
|
CD CADMIUM ION × 22
B2W 5-(trifluoromethyl)-2,3-dihydro-1~{H}-1,4-diazepine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;Apo crystals were grown in 0.6 M NaAcetate pH 7.5, 0.175 M cadmium sulphate (ML).
Crystals were then transferred into a drop supplemented with 10 mM ligand and incubated for 4 h. Crystals were cryo-protected by short immersion in ML supplemented with 20% glycerol and saturated with ligand.
|
Resolution 2.60 Å
R-free 0.221
|
|
6RHE
CpOGA D298N in complex with hOGA-derived S-GlcNAc peptide
Deposited 2019-04-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
31–619(589 aa)
|
Mutation:D298N
|
CD CADMIUM ION × 25
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;1:1 drops of proytein mixed with crystallisation buffer: 0.175 M CdSO4 and 0.6 M NaAc
|
Resolution 3.10 Å
R-free 0.233
|